| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9799 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.5188 |
| P-glycoprotein Substrate | Substrate | 0.7654 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9561 |
| Non-inhibitor | 0.9414 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5559 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6043 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8249 |
| CYP450 2D6 Substrate | Substrate | 0.7288 |
| CYP450 3A4 Substrate | Non-substrate | 0.5196 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6487 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8866 |
| CYP450 2D6 Inhibitor | Inhibitor | 0.5213 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8114 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9454 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6455 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8826 |
| Non-inhibitor | 0.7714 |
| AMES Toxicity | Non AMES toxic | 0.8158 |
| Carcinogens | Non-carcinogens | 0.9548 |
| Fish Toxicity | High FHMT | 0.7300 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8241 |
| Honey Bee Toxicity | Low HBT | 0.5243 |
| Biodegradation | Not ready biodegradable | 0.9962 |
| Acute Oral Toxicity | II | 0.4779 |
| Carcinogenicity (Three-class) | Non-required | 0.5981 |